Cargando…
Re-Assessment of the Oral Salt Loading Test Using a New Chemiluminescent Enzyme Immunoassay Based on a Two-Step Sandwich Method to Measure 24-Hour Urine Aldosterone Excretion
Since April 2021, the plasma aldosterone concentration has been measured by chemiluminescent enzyme immunoassay (CLEIA) in Japan. In the present study, we developed a new CLEIA using a two-step sandwich method to measure the 24-hour urine aldosterone level. We collected 115 urine samples and measure...
Autores principales: | Ozeki, Yoshinori, Kinoshita, Mizuki, Miyamoto, Shotaro, Yoshida, Yuichi, Okamoto, Mitsuhiro, Gotoh, Koro, Masaki, Takayuki, Kambara, Kengo, Shibata, Hirotaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977523/ https://www.ncbi.nlm.nih.gov/pubmed/35388294 http://dx.doi.org/10.3389/fendo.2022.859347 |
Ejemplares similares
-
Development of a New Chemiluminescent Enzyme Immunoassay Using a Two-Step Sandwich Method for Measuring Aldosterone Concentrations
por: Ozeki, Yoshinori, et al.
Publicado: (2021) -
Oral Salt Loading Test is Associated With 24-Hour Blood Pressure and Organ Damage in Primary Aldosteronism Patients
por: Yoshida, Yuichi, et al.
Publicado: (2020) -
Quality of Life of Primary Aldosteronism Patients by Mineralocorticoid Receptor Antagonists
por: Yoshida, Yuichi, et al.
Publicado: (2021) -
Pitfalls in the diagnosis and treatment of a hypertensive patient with unilateral primary aldosteronism and contralateral pheochromocytoma: a case report
por: Miyamoto, Shotaro, et al.
Publicado: (2023) -
Glucagon-Like Peptide-1 Receptor Agonist Semaglutide Improves Eating Behavior and Glycemic Control in Japanese Obese Type 2 Diabetic Patients
por: Masaki, Takayuki, et al.
Publicado: (2022)